Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.55 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.53 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.53 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.53 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29638033 | 1.00 | CYP1A2 (0.64) | CYP1A2TDP1ALDH1A1GPR35TSHR | |
| SCHEMBL395679 | 0.89 | CYP1A2 (0.60) | CYP1A2TDP1ALDH1A1GPR35TSHR | |
| SCHEMBL27961047 | 0.88 | CYP1A2 (0.68) | CYP1A2TDP1ALDH1A1GPR35TSHR | |
| SCHEMBL5333075 | 0.86 | CYP1A2 (0.66) | CYP1A2TDP1ALDH1A1GPR35TSHR | |
| SCHEMBL8887647 | 0.85 | ALDH1A1 (0.68) | CYP1A2TDP1ALDH1A1GPR35TSHR | |
| SCHEMBL10890268 | 0.84 | CYP1A2 (0.64) | CYP1A2TDP1ALDH1A1GPR35TSHR | |
| SCHEMBL10891708 | 0.84 | CYP1A2 (0.64) | CYP1A2TDP1ALDH1A1GPR35TSHR | |
| SCHEMBL7665273 | 0.84 | CYP1A2 (0.64) | CYP1A2TDP1ALDH1A1GPR35TSHR | |
| SCHEMBL6830861 | 0.84 | GPR35 (0.55) | CYP1A2TDP1ALDH1A1GPR35TSHR | |
| SCHEMBL7566464 | 0.83 | POLB (0.59) | CYP1A2TDP1ALDH1A1TSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11834383-B2 | Energetic feedstock for additive manufacturing | LYNNTECH, INC. (US) | 2023-12-05 | — | — | US | claimed |
| US-20210276931-A1 | Energetic Feedstock for Additive Manufacturing | LYNNTECH, INC. | 2021-09-09 | — | — | US | claimed |
| US-20180170821-A1 | PROPELLANT | GOODRICH CORPORATION (US) | 2018-06-21 | — | — | US | claimed |
| EP-1310487-B1 | PROCESSES FOR PREPARATION OF BICYCLIC COMPOUNDS AND INTERMEDIATES THEREFOR | DAIICHI SEIYAKU CO (JP) | 2007-01-03 | — | — | EP | claimed |
| US-20050272797-A1 | Processes for preparation of bicyclic compounds and intermediates therefor | DAIICHI PHARMACEUTICAL CO., LTD. | 2005-12-08 | — | — | US | claimed |
| US-20040019223-A1 | Processes for preparation of bicyclic compounds and intermediates therefor | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-01-29 | — | — | US | claimed |
| EP-1321505-A2 | Gelled propellant, process for the preparation of a gelled propellant and its use | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2003-06-25 | — | — | EP | claimed |
| EP-1310487-A1 | PROCESSES FOR PREPARATION OF BICYCLIC COMPOUNDS AND INTERMEDIATES THEREFOR | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2003-05-14 | — | — | EP | claimed |
| CN-117924177-A | Preparation method of pazopanib intermediate 2, 3-dimethyl-6-amino-2H-indazole and analogues thereof | 南京杰运医药科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-11834383-B2 | Energetic feedstock for additive manufacturing | LYNNTECH, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| CN-114539064-A | Synthesis method of 4-nitrophenylethane | 南通大学 | 2022-05-27 | — | — | CN | disclosed |
| CN-113408564-A | Graph processing method, network training method, device, equipment and storage medium | 腾讯科技（深圳）有限公司 | 2021-09-17 | — | — | CN | disclosed |
| US-20210276931-A1 | Energetic Feedstock for Additive Manufacturing | LYNNTECH, INC. | 2021-09-09 | — | — | US | disclosed |
| US-10717700-B2 | Nitration of aromatic compounds | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2020-07-21 | — | — | US | disclosed |
| US-5856518-A | Production process of cyclic compound | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1999-01-05 | — | — | US | disclosed |
| WO-1998056807-A1 | SOLID PHASE NATIVE CHEMICAL LIGATION OF UNPROTECTED OR N-TERMINAL CYSTEINE PROTECTED PEPTIDES IN AQUEOUS SOLUTION | GRYPHON SCIENCES (US) | 1998-12-17 | — | — | WO | disclosed |
| EP-0829473-A1 | PROCESSES FOR PREPARING CYCLIC COMPOUNDS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1998-03-18 | — | — | EP | disclosed |
| US-5086128-A | HIGH MOLECULAR WEIGHT ARYLENE SULPHIDE POLYMER MELT MIXED WITH AROMATIC NITRO COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1992-02-04 | — | — | US | disclosed |
| WO-1991013049-A1 | CHEMICAL ALTERATION OF A HYDROPHOBIC SUBSTANCE IN POLYMERIC MICROREGIONS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1991-09-05 | — | — | WO | disclosed |
| EP-0345550-A2 | High molecular weight arylene sulphide polymers | BAYER AG (DE) | 1989-12-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10717700-B2 | Nitration of aromatic compounds | NOS2, NOS1, NOS3 | CYP1A2 26/4885TDP1 1210/4885ALDH1A1 315/4885 |
| US-20040019223-A1 | Processes for preparation of bicyclic compounds and intermediates therefor | DCXR, CYP51A1, WEE1 | CYP1A2 523/4885TDP1 2971/4885ALDH1A1 3657/4885 |
| US-20050272797-A1 | Processes for preparation of bicyclic compounds and intermediates therefor | DCXR, WEE1, CYP51A1 | CYP1A2 564/4885TDP1 3157/4885ALDH1A1 3827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.